SCYM Fluorochrome Selection 5 — Questions and Answers
Question 1: When selecting fluorochromes for a clinical diagnostic panel, which regulatory consideration is most critical?
- Using only fluorochromes with the highest RBI
- Selecting FDA-cleared reagents validated for the intended clinical application (Correct answer)
- Choosing fluorochromes exclusive to research-grade cytometers
- Avoiding tandem dyes entirely
Correct answer: Selecting FDA-cleared reagents validated for the intended clinical application
Clinical panels must use FDA-cleared or validated reagents to ensure diagnostic accuracy, reproducibility, and regulatory compliance.
Question 2: Fluorochrome-conjugated antibodies stored incorrectly in light can degrade due to which phenomenon?
- Thermal denaturation
- Oxidative quenching from ambient light exposure (photobleaching) (Correct answer)
- Freeze-thaw protein aggregation
- Antibody isotype switching
Correct answer: Oxidative quenching from ambient light exposure (photobleaching)
Exposure to ambient light causes photobleaching of fluorochromes, reducing conjugate brightness and increasing lot-to-lot variability.
Question 3: Which of the following is the correct approach when a required marker has very low density on the cell surface (dim antigen)?
- Pair it with a dim fluorochrome to conserve bright dyes for housekeeping markers
- Pair it with the brightest available fluorochrome to maximize signal (Correct answer)
- Use an unconjugated primary antibody with no secondary
- Avoid including the marker in the panel
Correct answer: Pair it with the brightest available fluorochrome to maximize signal
Dim antigens must be paired with the brightest fluorochromes available to ensure the signal rises above background noise.
Question 4: What is the main reason BV dyes (Brilliant Violet) should not be used with certain detergent-based permeabilization buffers?
- BV dyes are incompatible with blue-laser excitation after permeabilization
- Detergents can cause BV dye aggregation, increasing background fluorescence (Correct answer)
- BV dyes dissolve cell membranes when combined with detergents
- BV dyes quench completely in the presence of saponin
Correct answer: Detergents can cause BV dye aggregation, increasing background fluorescence
Certain detergent-based permeabilization buffers cause BV polymer dyes to aggregate, producing high nonspecific background and altered spectral profiles.
Question 5: Which approach allows the detection of two proteins expressed at similar levels using fluorochromes with overlapping spectra?
- Using higher antibody concentrations for both markers
- Selecting fluorochromes on different laser lines to eliminate co-excitation (Correct answer)
- Increasing detector gain to separate the signals
- Using only one marker and inferring the second by subtraction
Correct answer: Selecting fluorochromes on different laser lines to eliminate co-excitation
Placing spectrally similar fluorochromes on different laser lines avoids co-excitation and enables independent signal detection for both markers.
Question 6: In a panel optimized for rare event detection (e.g., circulating tumor cells), which combination of strategies is most appropriate?
- Bright fluorochromes for all markers and high event counts (Correct answer)
- Dim dyes and low event counts to reduce background
- Unconjugated antibodies to avoid nonspecific staining
- Reduction in laser power to prevent photobleaching of the rare population
Correct answer: Bright fluorochromes for all markers and high event counts
Rare event detection requires maximum brightness for all markers and acquisition of large event numbers to accumulate sufficient rare-cell statistics.
Question 7: Which fluorochrome property determines how efficiently it captures photons from the excitation source?
- Quantum yield
- Molar extinction coefficient (Correct answer)
- Emission peak wavelength
- Stokes shift
Correct answer: Molar extinction coefficient
The molar extinction coefficient describes how strongly a fluorochrome absorbs light at its excitation wavelength, determining photon capture efficiency.
When selecting fluorochromes for a clinical diagnostic panel, which regulatory consideration is most critical?